3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
55
Multiple Myeloma
53
Hodgkin Disease
51
Precursor Cell Lymphoblastic Leukemia-Lymphoma
48
Lymphoma, Non-Hodgkin
46
Leukemia, Lymphocytic, Chronic, B-Cell
44
Myelodysplastic Syndromes
41
Lymphoma, Mantle-Cell
39
Lymphoma, Large B-Cell, Diffuse
38
Lymphoma, Follicular
36
Leukemia
36
Congenital Abnormalities
36
Burkitt Lymphoma
34
Myeloproliferative Disorders
31
Lymphoma
30
Lymphoma, B-Cell, Marginal Zone
29
Lymphoma, Large-Cell, Immunoblastic
28
Leukemia, Myeloid, Accelerated Phase
27
Leukemia, Myeloid, Chronic-Phase
26
Waldenstrom Macroglobulinemia
25
Blast Crisis
25
Leukemia, Myelomonocytic, Chronic
24
Recurrence
19
Primary Myelofibrosis
19
Lymphoma, T-Cell, Cutaneous
19
Neoplasms, Plasma Cell
18
Lymphoma, Large-Cell, Anaplastic
18
Myelodysplastic-Myeloproliferative Diseases
16
Sezary Syndrome
15
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
15
Interventions
Epoetin Alfa
7
Darbepoetin alfa
6
epoetin beta
4
Lenalidomide
4
Cyclophosphamide
4
ACE-011
4
fludarabine
3
Busulfan
3
thymoglobulin
2
telapristone acetate
2
luspatercept
2
fludarabine phosphate
2
Cyclosporine
2
Antilymphocyte Serum
2
AP 1903 reagent
2
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
vactosertib
1
ruxolitinib
1
roxadustat
1
obinutuzumab
1
ibrutinib
1
fosphenytoin
1
ferrous sulfate
1
ferric gluconate
1
ferric carboxymaltose
1
eltrombopag
1
angiotensin I (1-7)
1
Whole-Body Irradiation
1
Thiotepa
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Anemia
×
Peripheral Blood Stem Cell Transplantation
×
Clear all
No trials found.